C. Luderschmidt

868 total citations
32 papers, 619 citations indexed

About

C. Luderschmidt is a scholar working on Dermatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, C. Luderschmidt has authored 32 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 11 papers in Pathology and Forensic Medicine and 11 papers in Epidemiology. Recurrent topics in C. Luderschmidt's work include Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). C. Luderschmidt is often cited by papers focused on Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). C. Luderschmidt collaborates with scholars based in Germany, United States and Israel. C. Luderschmidt's co-authors include Gerd Plewig, Otto Braun‐Falco, Thomas Krieg, Rupert Timpl, Waltraud Dessau, Manfred Wiestner, Raúl Fleischmajer, Edward K. L. Chan, Kiyoshi Furuta and Georg Reimer and has published in prestigious journals such as CHEST Journal, Journal of Investigative Dermatology and Ecotoxicology and Environmental Safety.

In The Last Decade

C. Luderschmidt

29 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Luderschmidt Germany 14 219 186 150 120 94 32 619
H Perrot France 15 109 0.5× 211 1.1× 112 0.7× 266 2.2× 48 0.5× 81 634
David L. Cram United States 16 326 1.5× 277 1.5× 126 0.8× 135 1.1× 36 0.4× 28 784
Barbara Wilkinson Australia 10 87 0.4× 343 1.8× 226 1.5× 91 0.8× 50 0.5× 13 710
R. Piccinno Italy 19 153 0.7× 487 2.6× 321 2.1× 143 1.2× 50 0.5× 72 984
L Illig Germany 14 94 0.4× 226 1.2× 80 0.5× 90 0.8× 61 0.6× 80 767
Hideharu Endo Japan 11 202 0.9× 146 0.8× 90 0.6× 136 1.1× 96 1.0× 21 840
T.J. Stoof Netherlands 15 109 0.5× 262 1.4× 98 0.7× 139 1.2× 46 0.5× 29 810
Ken Hashimoto United States 15 114 0.5× 238 1.3× 101 0.7× 115 1.0× 20 0.2× 42 597
M. Paradisi Italy 12 118 0.5× 159 0.9× 67 0.4× 81 0.7× 18 0.2× 38 467
M.R. JUDGE United Kingdom 12 61 0.3× 165 0.9× 64 0.4× 113 0.9× 33 0.4× 27 503

Countries citing papers authored by C. Luderschmidt

Since Specialization
Citations

This map shows the geographic impact of C. Luderschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Luderschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Luderschmidt more than expected).

Fields of papers citing papers by C. Luderschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Luderschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Luderschmidt. The network helps show where C. Luderschmidt may publish in the future.

Co-authorship network of co-authors of C. Luderschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of C. Luderschmidt. A scholar is included among the top collaborators of C. Luderschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Luderschmidt. C. Luderschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jian‐Ming, Bernhard Hildebrandt, C. Luderschmidt, & K. Michael Pollard. (2003). Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Arthritis & Rheumatism. 48(1). 210–217. 35 indexed citations
2.
Renaudineau, Yves, Eyal Grunebaum, Ilan Krause, et al.. (2001). Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies. Autoimmunity. 33(3). 171–179. 39 indexed citations
3.
Furuta, Kiyoshi, et al.. (1998). . Journal of Molecular Medicine. 76(1). 54–60. 9 indexed citations
4.
Furuta, Kiyoshi, Edward K. L. Chan, Kendo Kiyosawa, et al.. (1997). Heterochromatin protein HP1 Hsβ (p25β) and its localization with centromeres in mitosis. Chromosoma. 106(1). 11–19. 56 indexed citations
5.
Furuta, Kiyoshi, Bernhard Hildebrandt, Kendo Kiyosawa, et al.. (1997). Immunological characterization of heterochromatin protein p25β autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma. Journal of Molecular Medicine. 76(1). 54–60. 10 indexed citations
6.
Luderschmidt, C.. (1996). Diagnostische und prognostische Parameter der Progressiven systemischen Sklerodermie. Aktuelle Rheumatologie. 21(4). 171–177. 2 indexed citations
7.
Benbassat, Carlos, M Schlesinger, C. Luderschmidt, et al.. (1993). The complement system and systemic sclerosis. Immunologic Research. 12(3). 312–316. 13 indexed citations
8.
Zurgil, Neomi, Ronit Bakimer, H M Moutsopoulos, et al.. (1992). Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. Journal of Clinical Immunology. 12(3). 201–209. 36 indexed citations
9.
Luderschmidt, C.. (1987). [Neuroendocrine (Merkel cell?) carcinoma of the skin].. PubMed. 62(4). 290–302. 1 indexed citations
10.
Eiermann, W., et al.. (1985). [Steroid receptors in malignant melanomas].. PubMed. 36(7). 393–7. 1 indexed citations
11.
Nissen, H. P. & C. Luderschmidt. (1985). Neue Erkenntnisse zur Bedeutung der Hautoberflächenlipide bei der Akne. Fette Seifen Anstrichmittel. 87(13-14). 567–570.
12.
Hehlmann, Rüdiger, et al.. (1984). Relapsing acute febrile neutrophilic dermatosis and essential thrombocythemia. PubMed. 48(5). 297–305. 17 indexed citations
13.
Luderschmidt, C., et al.. (1984). 17?-Propylmesterolone (SH 434): an antiandrogenic sebosuppressive substance not influencing circulating testosterone concentrations. Naunyn-Schmiedeberg s Archives of Pharmacology. 328(2). 214–218. 11 indexed citations
14.
Luderschmidt, C., F. Bidlingmaier, & Gerd Plewig. (1982). Inhibition of Sebaceous Gland Activity by Spironolactone in Syrian Hamster. Journal of Investigative Dermatology. 78(3). 253–255. 17 indexed citations
15.
Renner, G., et al.. (1981). Subchronic toxicity studies on pentachloronitrosobenzene (PCNO) in female rats. Ecotoxicology and Environmental Safety. 5(3). 281–290.
16.
Luderschmidt, C., et al.. (1981). [Apthae: histologic, immunofluorescent and immuno--electron microscopy study of their pathogenesis].. PubMed. 32(7). 364–9. 4 indexed citations
17.
Luderschmidt, C. & Helmut H. Wolff. (1980). Subtle clues to diagnosis of skin diseases by electron microscopy. American Journal of Dermatopathology. 2(1). 57–62. 5 indexed citations
18.
Braun‐Falco, Otto, C. Luderschmidt, Wojciech Maciejewski, & R. Scherer. (1978). [Generalized acute pustulosis. An unusual presentation of leukocytoclastic vasculitis].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(7). 371–7. 19 indexed citations
19.
Luderschmidt, C. & Gerd Plewig. (1978). Circumscribed Sebaceous Gland Hyperplasia: Autoradiographic and Histoplanimetric Studies. Journal of Investigative Dermatology. 70(4). 207–209. 27 indexed citations
20.
Plewig, Gerd & C. Luderschmidt. (1977). HAMSTER EAR MODEL FOR SEBACEOUS GLANDS. Journal of Investigative Dermatology. 68(4). 171–176. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Perrot Breakdown of academic impact, for papers by David L. Cram Breakdown of academic impact, for papers by Barbara Wilkinson Breakdown of academic impact, for papers by R. Piccinno Breakdown of academic impact, for papers by L Illig Breakdown of academic impact, for papers by Hideharu Endo Breakdown of academic impact, for papers by T.J. Stoof Breakdown of academic impact, for papers by Ken Hashimoto Breakdown of academic impact, for papers by M. Paradisi Breakdown of academic impact, for papers by M.R. JUDGE
Rankless by CCL
2026